HINGE HEALTH INC-A (HNGE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:HNGE • US4333131039

31.79 USD
-1.46 (-4.39%)
At close: Feb 5, 2026
31 USD
-0.79 (-2.49%)
After Hours: 2/5/2026, 5:41:02 PM
Fundamental Rating

4

HNGE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While HNGE seems to be doing ok healthwise, there are quite some concerns on its profitability. HNGE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year HNGE has reported negative net income.
HNGE Yearly Net Income VS EBIT VS OCF VS FCFHNGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 -50M -100M

1.2 Ratios

  • The Return On Assets of HNGE (-87.87%) is worse than 90.20% of its industry peers.
  • With a Return On Equity value of -165.85%, HNGE is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -87.87%
ROE -165.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNGE Yearly ROA, ROE, ROICHNGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

  • HNGE's Gross Margin of 77.28% is amongst the best of the industry. HNGE outperforms 92.16% of its industry peers.
  • HNGE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNGE Yearly Profit, Operating, Gross MarginsHNGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • HNGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • HNGE has about the same amout of shares outstanding than it did 1 year ago.
  • There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HNGE Yearly Shares OutstandingHNGE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M
HNGE Yearly Total Debt VS Total AssetsHNGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.29, we must say that HNGE is in the distress zone and has some risk of bankruptcy.
  • HNGE has a worse Altman-Z score (1.29) than 61.76% of its industry peers.
  • There is no outstanding debt for HNGE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACCN/A
WACC8.93%
HNGE Yearly LT Debt VS Equity VS FCFHNGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • HNGE has a Current Ratio of 1.85. This is a normal value and indicates that HNGE is financially healthy and should not expect problems in meeting its short term obligations.
  • HNGE has a better Current ratio (1.85) than 74.51% of its industry peers.
  • A Quick Ratio of 1.81 indicates that HNGE should not have too much problems paying its short term obligations.
  • HNGE has a Quick ratio of 1.81. This is in the better half of the industry: HNGE outperforms 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.81
HNGE Yearly Current Assets VS Current LiabilitesHNGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • HNGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.96%, which is quite impressive.
  • HNGE shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.37%.
EPS 1Y (TTM)88.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)33.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, HNGE will show a very strong growth in Earnings Per Share. The EPS will grow by 84.54% on average per year.
  • The Revenue is expected to grow by 24.99% on average over the next years. This is a very strong growth
EPS Next Y1066.95%
EPS Next 2Y249.03%
EPS Next 3Y144.96%
EPS Next 5Y84.54%
Revenue Next Year49.9%
Revenue Next 2Y35.36%
Revenue Next 3Y28.97%
Revenue Next 5Y24.99%

3.3 Evolution

HNGE Yearly Revenue VS EstimatesHNGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
HNGE Yearly EPS VS EstimatesHNGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HNGE. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 20.41, the valuation of HNGE can be described as rather expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HNGE.
  • HNGE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 20.41
HNGE Price Earnings VS Forward Price EarningsHNGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HNGE Per share dataHNGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HNGE's earnings are expected to grow with 144.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y249.03%
EPS Next 3Y144.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HNGE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HINGE HEALTH INC-A

NYSE:HNGE (2/5/2026, 5:41:02 PM)

After market: 31 -0.79 (-2.49%)

31.79

-1.46 (-4.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-10
Inst Owners101.65%
Inst Owner Change5.12%
Ins Owners5.33%
Ins Owner Change-14.72%
Market Cap2.50B
Revenue(TTM)807.54M
Net Income(TTM)-676.46M
Analysts82.86
Price Target64.6 (103.21%)
Short Float %13.84%
Short Ratio3.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)397.95%
Min EPS beat(2)92.15%
Max EPS beat(2)703.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.58%
Min Revenue beat(2)6.37%
Max Revenue beat(2)8.79%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.48%
PT rev (3m)-0.6%
EPS NQ rev (1m)-1.57%
EPS NQ rev (3m)61.98%
EPS NY rev (1m)70.42%
EPS NY rev (3m)148.65%
Revenue NQ rev (1m)0.4%
Revenue NQ rev (3m)7.68%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)4.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.41
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 6.14
P/tB 7.34
EV/EBITDA N/A
EPS(TTM)-14.4
EYN/A
EPS(NY)1.56
Fwd EY4.9%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.26
BVpS5.18
TBVpS4.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -87.87%
ROE -165.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.28%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.81
Altman-Z 1.29
F-ScoreN/A
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y1066.95%
EPS Next 2Y249.03%
EPS Next 3Y144.96%
EPS Next 5Y84.54%
Revenue 1Y (TTM)33.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year49.9%
Revenue Next 2Y35.36%
Revenue Next 3Y28.97%
Revenue Next 5Y24.99%
EBIT growth 1Y81.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year569.65%
EBIT Next 3Y115.07%
EBIT Next 5Y71.84%
FCF growth 1Y166.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y176.68%
OCF growth 3YN/A
OCF growth 5YN/A

HINGE HEALTH INC-A / HNGE FAQ

What is the fundamental rating for HNGE stock?

ChartMill assigns a fundamental rating of 4 / 10 to HNGE.


What is the valuation status of HINGE HEALTH INC-A (HNGE) stock?

ChartMill assigns a valuation rating of 3 / 10 to HINGE HEALTH INC-A (HNGE). This can be considered as Overvalued.


What is the profitability of HNGE stock?

HINGE HEALTH INC-A (HNGE) has a profitability rating of 1 / 10.